Director, US GI Market Research

Revolution Medicines•Redwood City, CA
•$211,000 - $264,000•Hybrid

About The Position

The Director, US GI Market Research serves as the US Market Research lead for Revolution Medicines’ GI cancer portfolio and reports to the Senior Director, US GI Analytics & Insights. The role partners with US Commercial, US Market Access, Global Market Research, Medical Affairs, Clinical Development, and Business Operations to generate actionable insights that inform portfolio strategy, launch readiness, commercialization planning, and business performance. The position requires a strong understanding of the PDAC and CRC treatment landscape, patient journeys, biomarker-driven markets, and oncology data assets. It is based at the company’s Redwood City, California headquarters, with flexibility for remote candidates who are willing to travel regularly to the office. Travel is also required as needed.

Requirements

  • Bachelor’s degree required; advanced degree preferred.
  • 10+ years of progressive experience in a pharmaceutical, biotechnology, or strategic consulting role.
  • 6+ years of experience in a strategic analytics role.
  • Oncology market research experience.
  • Experience in market development and new product launches.
  • Extensive primary research and secondary analytical skills, including the ability to translate data and learning into actionable recommendations for business growth.
  • Collaborative team-player skills and adaptability to meet the needs of a growing business.
  • Strong problem-solving skills and experience leveraging varied research and analytical vendors and study designs, and building quality research vendor partnerships.
  • Demonstrated ability to influence senior management and key business partners.
  • Proven experience in a smaller, rapidly growing company.
  • Excellent organizational skills and ability to prioritize effectively and deliver within reasonably established timelines.
  • Strong interpersonal, verbal, and written communication skills and ability to represent the company well with internal and external stakeholders.
  • Entrepreneurial mindset, tolerance for ambiguity, and passion for helping cancer patients.

Nice To Haves

  • MBA, MPH, MS, or PhD.
  • GI cancer experience, particularly in PDAC and/or CRC.
  • Deep understanding of PDAC and/or CRC and biomarker-driven oncology markets.
  • Experience supporting targeted oncology therapies.
  • Prior experience in a growth-stage biotechnology company.

Responsibilities

  • Lead, design, and execute US primary market research projects with healthcare professionals, patients, and payors.
  • Initiate and facilitate activities that improve partners’ understanding of the US market and potential product attitudes, usage, market dynamics, and competition, including treatment flows, target product profiles, opportunity assessments, and market landscape research.
  • Communicate the voice of the US community, including physicians, patients, and payors, by maintaining and sharing a holistic marketplace understanding synthesized from primary and secondary sources.
  • Reinforce market research best practices; identify suitable market research and data sources, vendors, and methodologies; and manage third parties associated with the function.
  • Align internal stakeholders on research objectives and outputs, qualify findings based on data strength, and identify limitations.
  • Develop and present timely final reports and actionable recommendations to stakeholders and senior leadership, emphasizing key findings and relevant implications.
  • Communicate insights and strategic implications to senior leadership through clear, concise, and compelling recommendations.
  • Shape situation analysis as part of launch planning and partner with marketing, sales when appropriate, access, and medical teams to provide a comprehensive view of the market.
  • Quickly understand complex markets, disease states, competitive landscapes, and relevant market and managed-care dynamics.
  • Apply analytical rigor to valuation of business opportunities and quantification of risk.
  • Partner with US Forecasting, US Data Analytics, and Competitive Intelligence colleagues to develop an integrated view of market performance and future growth opportunities.
  • Travel as needed.

Benefits

  • Competitive cash compensation.
  • Robust equity awards.
  • Strong benefits.
  • Significant learning and development opportunities.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service